CONVERTHERA NAD PLUS PATCH- converthera nad plus patch patch
Through Medical INC.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Apply the patch to skin firmly.
Leave on for 4-6 hours, then remove and discard.
Use 1-2 patches per week as needed or as directed by a licensed provider.

Warnings:
For external use only. Do not exceed the recom- mended dose. Do not apply to broken, irritated, or sensitive skin. Mild redness or tingling may occur and is considered normal. Discontinue use if irritation or rash develops. Pregnant or nursing mothers, children under 18, or individu- als with known medical conditions should consult a physician before use. KEEP OUT OF REACH OF CHILDREN. DO NOT USE IF SAFETY SEAL IS DAMAGED OR MISSING. STORE IN A COOL, DRY PLACE.

Other Ingredients: Transdermal patch layer with hydrogel matrix and backing film.

Clean a dry, hair-free area (upper arm, abdomen, or back).
Add 8-10 drops of NAD+ solution to the patch.
Apply the patch to skin firmly.
Leave on for 4-6 hours, then remove and discard.

KEEP OUT OF REACH OF CHILDREN.

NAD+
(Nicotinamide Adenine
250 mg

Dinucleotide)
Vitamin B12
15,000 mcg

Glutathione

Use 1-2 patches per week as needed or as directed by a licensed provider.

Content of Labeling Labeling

CONVERTHERA NAD PLUS PATCH
converthera nad plus patch patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:85945-0001
Route of Administration	TRANSDERMAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NICOTINAMIDE ADENINE DINUCLEOTIDE (UNII: 0U46U6E8UK) (NICOTINAMIDE ADENINE DINUCLEOTIDE - UNII:0U46U6E8UK)	NICOTINAMIDE ADENINE DINUCLEOTIDE	250 mg in 1 U
GLUTATHIONE (UNII: GAN16C9B8O) (GLUTATHIONE - UNII:GAN16C9B8O)	GLUTATHIONE	25 mg in 1 U

Ingredient Name	Strength
Inactive Ingredients
LACTOSE (UNII: J2B2A4N98G)
GLUTENIN (UNII: FX065C7O71)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:85945-0001-1	30 U in 1 PATCH; Type 0: Not a Combination Product	07/01/2025
2	NDC:85945-0001-2	8 U in 1 PATCH; Type 0: Not a Combination Product	07/01/2025

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		07/01/2025

Labeler - Through Medical INC. (134422688)

Registrant - Through Medical INC. (134422688)

Name	Address	ID/FEI	Business Operations
Establishment
Through Medical INC.		134422688	manufacture(85945-0001)